Preclinical investigation reveals that STRIP2 promotes tumor progression in lung adenocarcinoma through PI3K/AKT/mTOR/MYC signaling, indicating its potential as a therapeutic target.
Patients with lung adenocarcinoma (LUAD) generally have poor prognosis. The role of striatin-interacting protein 2 (STRIP2) in LUAD remain unclear.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: